Bibliography

Export 6 results:

Filters: Keyword is Drug Administration Schedule and Author is Trofe,J. [Clear All Filters]

2005

Rogers CC, Hanaway M, Alloway RR, Alexander JW, Boardman RE, Trofe J, et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc. 2005;37(2):795-7.

Woodle ES, Alloway RR, Hanaway MJ, Buell JF, Thomas M, Roy-Chaudhury P, et al. Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection. Transplant Proc. 2005;37(2):798-9.

Boardman R, Trofe J, Alloway R, Rogers C, Roy-Chaudhury P, Cardi M, et al. Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc. 2005;37(2):817-8.

Rogers CC, Alloway RR, Boardman R, Trofe J, Hanaway MJ, Alexander JW, et al. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplant Proc. 2005;37(2):812-3.

Woodle ES, Alloway RR, Buell JF, Alexander JW, Munda R, Roy-Chaudhury P, et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740-4.

Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, et al. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.